Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis

Current Opinion in Rheumatology
Matthew J KosterKenneth J Warrington

Abstract

This article critically reviews the advances in medical management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) with a focus on recent developments in targeted biologic therapy. The role of biologics in the treatment of large vessel vasculitis (LVV) is expanding. TNFα inhibitors appear to be effective in the treatment of TAK but have little benefit in GCA. Preliminary clinical trial data suggest that abatacept and tocilizumab reduce the risk of relapse in GCA. Increasing observational evidence supports the use of interleukin-6 inhibitors in TAK. Based on a small open-label study, ustekinumab appears safe and potentially effective for refractory GCA. A possible role of B cell dysregulation may contribute to pathogenic mechanisms in LVV, but support for the use of B cell depleting therapy is limited. Interleukin-6 inhibitors appear efficacious in the treatment of refractory cases of LVV; however, utility in newly diagnosed immunosuppressive-naïve patients is less well established. Abatacept and ustekinumab are promising targets for therapy in LVV but further investigation is needed before routine use is considered.

References

Oct 1, 1994·Annals of Internal Medicine·C M WeyandJ J Goronzy
Mar 29, 2000·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·S J InderC Yutani
May 19, 2000·Arthritis and Rheumatism·C M WeyandJ J Goronzy
Jun 10, 2003·Arthritis and Rheumatism·Gregg J Silverman, Stuart Weisman
Jul 13, 2004·Arthritis and Rheumatism·Gary S HoffmanPatrick Liang
Jun 17, 2005·Annals of the Rheumatic Diseases·A BhatiaJ C W Edwards
May 2, 2007·Annals of Internal Medicine·Gary S HoffmanUNKNOWN Infliximab-GCA Study Group
Apr 15, 2009·Current Opinion in Rheumatology·Toru Mima, Norihiro Nishimoto
Jul 14, 2009·Medicine·Kathleen Maksimowicz-McKinnonGary S Hoffman
Feb 10, 2010·Circulation·Jiusheng DengCornelia M Weyand
Jan 12, 2011·Circulation·Kisha PiggottCornelia M Weyand
Apr 26, 2011·Annals of the Rheumatic Diseases·Christian BeyerJochen Zwerina
Aug 23, 2011·Autoimmunity Reviews·Laurent ArnaudZahir Amoura
Sep 3, 2011·The Journal of Rheumatology·Savino SciasciaDario Roccatello
Nov 15, 2011·Rheumatology·Carlo SalvaraniLuigi Boiardi
Feb 14, 2012·Annals of the Rheumatic Diseases·Peter C GraysonUNKNOWN Vasculitis Clinical Research Consortium
Sep 12, 2012·Rheumatology International·Metin IşıkMeral Calgüneri
Jul 31, 2013·Joint, Bone, Spine : Revue Du Rhumatisme·Kim-Heang LyAnne-Laure Fauchais
Nov 5, 2013·The Journal of Rheumatology·Enrico TombettiElena Baldissera
Nov 15, 2013·Current Opinion in Rheumatology·Alison Clifford, Gary S Hoffman
Jan 3, 2014·International Journal of Rheumatic Diseases·Ruchika GoelGeorge Joseph
Jan 7, 2014·Joint, Bone, Spine : Revue Du Rhumatisme·Franco SchiavonRoberta Ramonda
Mar 14, 2014·Arthritis & Rheumatology·Kornelis S M van der GeestElisabeth Brouwer
Mar 26, 2014·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Carlos Alberto CañasGabriel J Tobón
May 20, 2014·Cancer Immunology Research·F Stephen HodiDavid McDermott
Nov 25, 2014·Clinical Rheumatology·Ari PolachekOri Elkayam
Jan 22, 2015·Arthritis & Rheumatology·D SaadounP Cacoub
Feb 24, 2015·Seminars in Arthritis and Rheumatism·Javier LoriceraMiguel Á González-Gay
Apr 4, 2015·International Journal of Cardiology·Yoh AritaYasushi Sakata
Apr 15, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Mohammed OsmanElaine Yacyshyn

❮ Previous
Next ❯

Citations

Jul 21, 2016·Expert Opinion on Emerging Drugs·David Saadoun, Patrice Cacoub
Nov 24, 2016·Nature Reviews. Gastroenterology & Hepatology·Medha SoowamberChristian Pagnoux
Jan 25, 2017·Expert Review of Clinical Immunology·Francesco MuratoreCarlo Salvarani
Mar 23, 2017·Arthritis & Rheumatology·Sergey MoiseevIlya Smitienko
Jul 27, 2017·The New England Journal of Medicine·John H StoneNeil Collinson
Apr 4, 2018·Current Rheumatology Reports·M Guevara, C S Kollipara
Apr 25, 2018·The Journal of International Medical Research·Masakazu MatsushitaNaoto Tamura
Sep 8, 2017·Nature Reviews. Rheumatology·Matthew J Koster, Kenneth J Warrington
Oct 3, 2017·Rheumatology·Miguel A González-Gay, Santos Castañeda
Feb 24, 2018·QJM : Monthly Journal of the Association of Physicians·Masahiro YamasakiNoboru Hattori
Feb 23, 2019·Modern Rheumatology·Mitsuhiro AkiyamaTsutomu Takeuchi
Aug 15, 2017·Current Opinion in Cardiology·Ingolf Töpel
May 28, 2019·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Hubert de BoyssonAchille Aouba
Sep 24, 2016·Current Opinion in Rheumatology·Ilknur Tugal-Tutkun
Sep 1, 2017·BMC Research Notes·Klaus EmpenPiotr M Kaczmarek
Mar 8, 2017·Case Reports in Obstetrics and Gynecology·Sheeba MarwahSonam R Topden
Jul 10, 2018·Rheumatology·Frank ButtgereitBhaskar Dasgupta
Mar 18, 2021·Scandinavian Journal of Rheumatology·T ShiraiH Harigae
Jan 3, 2022·Joint, Bone, Spine : Revue Du Rhumatisme·Maxime SamsonBernard Bonnotte

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Clinical Trials Mentioned

NCT01791153
NCT02101333
NCT00556439

Related Concepts

Related Feeds

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.